IP Library Granted Patent US 8,076,355
Granted Patent B2
US 8,076,355 · App. 12/777,764 · Granted Dec 13, 2011

2-heteroarylcarboxylic acid amides

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,076,355
App. No.
12/777,764
Granted
Dec 13, 2011
Kind
B2
Abstract

The invention relates to novel 2-heteroarylcarboxamides, processes for their preparation, and their use for producing medicaments for the treatment and/or prophylaxis of diseases and for improving perception, concentration, learning and/or memory.

Claims (42)

1. A method for treating a cognitive impairment in a patient suffering from Alzheimer's disease or schizophrenia, the method comprising administering to a patient a therapeutically effective amount a compound of formula (I):

wherein

R 1 represents 1-azabicyclo[2.2.2]oct-3-yl,

R 2 represents hydrogen or C 1 -C 6 -alkyl,

R 3 represents hydrogen, halogen or C 1 -C 6 -alkyl,

A represents oxygen or sulfur,

and

the ring B represents benzo, pyrimido, pyrimidazo or pyridazino which is substituted by a radical selected from the group consisting of halogen, C 1 -C 6 -alkanoyl, carbamoyl, cyano, trifluoromethyl, trifluoromethoxy, nitro, amino, C 1 -C 6 -acylamino, C 1 -C 6 -alkyl, C 1 -C 6 -alkyoxy, C 1 -C 6 -alkylthio, C 1 -C 6 -alkylamino, heteroarylcarbonylamino, arylcarbonylamino, C 1 -C 6 -alkylsulfonyl-amino, di(C 1 -C 4 -alkylsulfonyl)amino, arylsulfonylamino, di(arylsulfonyl)amino, C 3 -C 6 -cycloalkylcarbonylmethyl, 1,3-dioxa-propane-1,3-diyl, amino(hydroxyimino)methyl and benzo,

or a salt, a hydrate or a hydrate of a salt thereof.

2. The method of claim 1 wherein the treatment improves one or more of perception, concentration, learning and memory in the subject.

3. The method of claim 1 ,

wherein

R 1 represents 1-azabicyclo[2.2.2]oct-3-yl,

R 2 represents hydrogen or C 1 -C 6 -alkyl,

R 3 represents hydrogen, halogen or C 1 -C 6 -alkyl,

A represents oxygen or sulfur,

and

the ring B represents benzo, pyrimido, pyridazo or pyridazino which is substituted by a radical selected from the group consisting of halogen, formyl, carbamoyl, cyano, trifluoromethyl, trifluoromethoxy, nitro, amino, formamido, acetamido, (C 1 -C 6 -alkyl, (C 1 -C 6 )-alkoxy, (C 1 -C 6 )-alkylthio and benzo,

or a salt, a hydrate or a hydrate of a salt thereof.

4. The method of claim 3 wherein the compound has formula (Ia):

wherein

R 1 represents 1-azabicyclo[2.2.2]oct-3-yl,

R 2 represents hydrogen or C 1 -C 6 -alkyl,

R 3 represents hydrogen, halogen or C 1 -C 6 -alkyl,

A represents oxygen or sulfur,

and

Z represents halogen, formyl, carbamoyl, cyano, trifluoromethyl, trifluoromethoxy, nitro, amino, formamido, acetamido, C1-C6-alkyl, C1-C6-alkyoxy, C1-C6-alkylthio, C1-C6-alkylamino, heteroaryl-carbonylamino, arylcarbonylamino, C1-C4-alkylsulfonylamino, di(arylsulfonyl)amino, C3-C6-cycloalkylcarbonylmethyl or amino(hydroxyimino)methyl,

or a salt, a hydrate or a hydrate of a salt thereof.

5. The method of claim 1 , wherein Z is selected from the group consisting of: halogen, cyano, trifluoromethyl, trifluoromethoxy, methyl, ethyl, methoxy, and ethoxy.

6. The method of claim 2 , wherein Z is selected from the group consisting of: halogen, cyano, trifluoromethyl, trifluoromethoxy, methyl, ethyl, methoxy, and ethoxy.

7. The method of claim 3 , wherein Z is selected from the group consisting of: halogen, cyano, trifluoromethyl, trifluoromethoxy, methyl, ethyl, methoxy, and ethoxy.

8. The method of claim 4 , wherein Z is selected from the group consisting of: halogen, cyano, trifluoromethyl, trifluoromethoxy, methyl, ethyl, methoxy, and ethoxy.

9. The method of claim 1 , wherein the compound is N-[(3R)-1-Azabicyclo[2.2.2]oct-3-yl]-7-fluoro-1-benzofuran-2-carboxamide.

10. The method of claim 1 , wherein the compound is N-[(3R)-1-Azabicyclo[2.2.2]oct-3-yl]-5-fluoro-1-benzothiophene-2-carboxamide.

11. The method of claim 1 , wherein the compound is N-[(3R)-1-Azabicyclo[2.2.2]oct-3-yl]-5,7-difluoro-1-benzothiophene-2-carboxamide.

12. The method of claim 1 , wherein the compound is N-[(3R)-1-Azabicyclo[2.2.2]oct-3-yl]-5-fluoro-1-benzofuran-2-carboxamide.

13. The method of claim 1 , wherein the compound is N-[(3R)-1-Azabicyclo[2.2.2]oct-3-yl]-5-chloro-1-benzofuran-2-carboxamide.

14. The method of claim 1 , wherein the compound is N-[(3R)-1-Azabicyclo[2.2.2]oct-3-yl]-5,7-difluoro-1-benzofuran-2-carboxamide.

15. The method of claim 1 , wherein the compound is N-[(3R)-1-Azabicyclo[2.2.2]oct-3-yl]-7-fluoro-1-benzothiophene-2-carboxamide.

16. The method of claim 1 , wherein the compound is N-[(3R)-1-Azabicyclo[2.2.2]oct-3-yl]-7-chloro-1-benzothiophene-2-carboxamide.

17. The method of claim 1 , wherein the compound is N-[(3R)-1-Azabicyclo[2.2.2]oct-3-yl]-7-cyano-1-benzothiophene-2-carboxamide.

18. The method of claim 1 , wherein the compound is N-[(3R)-1-Azabicyclo[2.2.2]oct-3-yl]-7-trifluoromethyl-1-benzothiophene-2-carboxamide.

Assignments (1)
SECURITY INTEREST Recorded Jul 5, 2016
From: FORUM PHARMACEUTICALS INC.
To: FMR LLC
Reel/Frame 039254/0828 →